Login to Your Account


'Star of ASH' offers BCMA findings

ATLANTA – About what he called "incredible" data with BB-2121 in multiple myeloma, Bluebird Bio Inc.'s chief medical officer, David Davidson, told BioWorld that his firm is "actually in a privileged position to have positive results across all of our clinical programs" at the scientific meeting.

more »


Analysis

The Good Pharma Scorecard (GPS) released last week by the not-for-profit Bioethics International contained surprisingly good news. Two companies – Johnson & Johnson (J&J) and Sanofi SA – of 11 ranked on overall clinical trial transparency, based on drugs approved in 2014, achieved scores of 100 percent, tying them at the top of the list. Four others – Abbvie Inc., Celgene Corp., Merck & Co. Inc. and Astrazeneca plc – scored at or above the industry median of 91 percent.

read more »

Opinion


Partners in Focus